Expression of the RAE-1 Family of Stimulatory NK-Cell Ligands Requires Activation of the PI3K Pathway during Viral Infection and Transformation
Open accessThe DOI matches its Crossref record; 57 of the 59 references it cites were found in a registry or an index.
Abstract
Natural killer (NK) cells are lymphocytes that play a major role in the elimination of virally-infected cells and tumor cells. NK cells recognize and target abnormal cells through activation of stimulatory receptors such as NKG2D. NKG2D ligands are self-proteins, which are absent or expressed at low levels on healthy cells but are induced upon cellular stress, transformation, or viral infection. The exact molecular mechanisms driving expression of these ligands remain poorly understood. Here we show that murine cytomegalovirus (MCMV) infection activates the phosphatidylinositol-3-kinase (PI3K) pathway and that this activation is required for the induction of the RAE-1 family of mouse NKG2D ligands. Among the multiple PI3K catalytic subunits, inhibition of the p110α catalytic subunit blocks this induction. Similarly, inhibition of p110α PI3K reduces cell surface expression of RAE-1 on transformed cells. Many viruses manipulate the PI3K pathway, and tumors frequently mutate the p110α oncogene. Thus, our findings suggest that dysregulation of the PI3K pathway is an important signal to induce expression of RAE-1, and this may represent a commonality among various types of cellular stresses that result in the induction of NKG2D ligands.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings are consistent with previous studies suggesting that NKG2D ligands are induced by a variety of other stimuli, including E2F transcription factors, PI3 kinase, Ras oncogene signaling, and an activated DNA damage response (Gasser et al., 2005; Tokuyama et al., 2011; Jung et al., 2012).”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Tokuyama et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,437
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Engelman, J. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2664 · Cited by 2,445
eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation
Gingras, A.-C., Raught, B., & Sonenberg, N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.913 · Cited by 2,121
Roles of the NKG2D immunoreceptor and its ligands
Raulet, D. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1199 · Cited by 1,348
Self-citationThe DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H. (2005) · Nature · doi:10.1038/nature03884 · Cited by 1,308
Self-citationBeyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis
Cully, M., You, H., Levine, A. J., & Mak, T. W. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1819 · Cited by 1,233
Walker, E. H., Pacold, M. E., Perisic, O., Stephens, L., Hawkins, P. T., Wymann, M. P., & Williams, R. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00089-4 · Cited by 1,197
A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
Knight, Z. A., Gonzalez, B., Feldman, M. E., Zunder, E. R., Goldenberg, D. D., Williams, O., Loewith, R., Stokoe, D., Balla, A., Toth, B., et al. (2006) · Cell · doi:10.1016/j.cell.2006.03.035 · Cited by 1,174
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
Diefenbach, A., Jensen, E. R., Jamieson, A. M., & Raulet, D. H. (2001) · Nature · doi:10.1038/35093109 · Cited by 1,083 · cited 2×
“Clearance in vivo is mediated by NK cells and in some cases CD8 T cells, despite expression of inhibitory MHC-I molecules in some tumor cells [6,24].”
BackgroundSelf-citationBroad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Cited by
Regulation of Ligands for the NKG2D Activating Receptor
Raulet, D. H., Gasser, S., Gowen, B. G., Deng, W., & Jung, H. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095951 · Cited by 848
Self-citationIannello, A., Thompson, T. W., Ardolino, M., Lowe, S. W., & Raulet, D. H. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130783 · Cited by 414
Self-citationRecognition of Tumors by the Innate Immune System and Natural Killer Cells
Marcus, A., Gowen, B. G., Thompson, T. W., Iannello, A., Ardolino, M., Deng, W., Wang, L., Shifrin, N., & Raulet, D. H. (2014) · Advances in Immunology · doi:10.1016/b978-0-12-800267-4.00003-1 · Cited by 394
Self-citationMolecular mechanisms of natural killer cell activation in response to cellular stress
Chan, C. J., Smyth, M. J., & Martinet, L. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.26 · Cited by 213
NKG2D Ligands in Tumor Immunity: Two Sides of a Coin
Zhang, J., Basher, F., & Wu, J. D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00097 · Cited by 146
Tissue-Resident NK Cells: Development, Maturation, and Clinical Relevance
Hashemi, E., & Malarkannan, S. (2020) · Cancers · doi:10.3390/cancers12061553 · Cited by 135
Balancing the innate immune system in tumor development
Hagerling, C., Casbon, A.-J., & Werb, Z. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.11.001 · Cited by 133
Jung, H., Hsiung, B., Pestal, K., Procyk, E., & Raulet, D. H. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120565 · Cited by 123
“The PI3K pathway, which supports RAE-1 expression in both virus-infected cells and tumor cell lines, may act in part by regulating protein translation as well as by stimulating cell proliferation (Tokuyama et al., 2011).”
BackgroundSelf-citationImmunosurveillance and immunotherapy of tumors by innate immune cells
Iannello, A., Thompson, T. W., Ardolino, M., Marcus, A., & Raulet, D. H. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.11.001 · Cited by 105
Self-citationRegulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway
Álvarez, M., Simonetta, F., Baker, J. B., Pierini, A., Wenokur, A. S., Morrison, A. R., Murphy, W. J., & Negrin, R. S. (2019) · JCI Insight · doi:10.1172/jci.insight.127729 · Cited by 105
Molecular Bases for the Regulation of NKG2D Ligands in Cancer
Huergo-Zapico, L., Acebes‐Huerta, A., López‐Soto, A., Villa-Ãlvarez, M. N., González, A. P., & Gonzalez, S. R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00106 · Cited by 80
Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression
Jones, A. B., Rocco, A., Lamb, L. S., Friedman, G. K., & Hjelmeland, A. B. (2022) · Cancers · doi:10.3390/cancers14092339 · Cited by 72
Raulet, D. H., Marcus, A., & Coscoy, L. (2017) · Immunological Reviews · doi:10.1111/imr.12600 · Cited by 65
Self-citationAdvances in NKG2D ligand recognition and responses by NK cells
Bert, N. L., & Gasser, S. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2013.111 · Cited by 64
Ras Activation Induces Expression of Raet1 Family NK Receptor Ligands
Liu, X. V., Ho, S. S. W., Tan, J. J., Kamran, N., & Gasser, S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200965 · Cited by 60
Immune Surveillance of Unhealthy Cells by Natural Killer Cells
Iannello, A., & Raulet, D. H. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020255 · Cited by 54
Self-citationEl-Jawhari, J. J., El-Sherbiny, Y. M., Scott, G. B., Morgan, R. S. M., Prestwich, R., Bowles, P. A., Blair, G. E., Tanaka, T., Rabbitts, T. H., Meade, J. L., et al. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2013.11.020 · Cited by 54
Manipulation of NKG2D ligands by cytomegaloviruses: impact on innate and adaptive immune response
Jonjić, S. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00085 · Cited by 50
Hu, L., Cao, D., Li, Y., He, Y., & Guo, K. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.19601 · Cited by 49
Brassington, K., Kanellakis, P., Cao, A. H., Toh, B., Peter, K., Bobik, A., & Kyaw, T. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1040233 · Cited by 38
Regulation of self-ligands for activating natural killer cell receptors
Lam, R. A., Chwee, J. Y., Bert, N. L., Sauer, M., von Strandmann, E. P., & Gasser, S. (2013) · Annals of Medicine · doi:10.3109/07853890.2013.792495 · Cited by 36
Chen, T., Zhu, L., Zhou, Y., Pi, B., Liu, X., Deng, G., Zhang, R., Wang, Y., Wu, Z., Han, M., et al. (2013) · Clinical Immunology · doi:10.1016/j.clim.2012.12.013 · Cited by 36
Paschen, A., Baingo, J., & Schadendorf, D. (2014) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2014.01.009 · Cited by 35
Role of inositol phospholipid signaling in natural killer cell biology
Gumbleton, M., & Kerr, W. G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00047 · Cited by 35
Natural killer cell effector functions in antiviral defense
Piersma, S. J., & Brizić, I. (2021) · FEBS Journal · doi:10.1111/febs.16073 · Cited by 34
Pignoloni, B., Fionda, C., Dell’Oste, V., Luganini, A., Cippitelli, M., Zingoni, A., Landolfo, S., Gribaudo, G., Santoni, A., & Cerboni, C. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502527 · Cited by 34
Baugh, R. T., Khalique, H., Page, E., Lei-Rossmann, J., Wan, P. K.-T., Johanssen, T., Ebner, D. V., Ansorge, O., & Seymour, L. W. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008460 · Cited by 33
Crystal Structure of the Cowpox Virus-Encoded NKG2D Ligand OMCP
Lazear, E., Peterson, L. W., Nelson, C. A., & Fremont, D. H. (2012) · Journal of Virology · doi:10.1128/jvi.01948-12 · Cited by 33
Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response
Baugh, R. T., Khalique, H., & Seymour, L. W. (2020) · Cancers · doi:10.3390/cancers12123827 · Cited by 29
Aguilar, O. A., Mesci, A., Ma, J., Chen, P., Kirkham, C. L., Hundrieser, J., Voigt, S., Allan, D., & Carlyle, J. R. (2015) · Journal of Innate Immunity · doi:10.1159/000382032 · Cited by 28
MCMV avoidance of recognition and control by NK cells
Brizić, I., Roviš, T. L., Krmpotić, A., & Jonjić, S. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0441-9 · Cited by 27
Greene, T. T., Tokuyama, M., Knudsen, G. M., Kunz, M., Lin, J., Greninger, A. L., DeFilippis, V. R., DeRisi, J. L., Raulet, D. H., & Coscoy, L. (2016) · eLife · doi:10.7554/elife.14749 · Cited by 25
Self-citationTumor-derived CSF-1 induces the NKG2D ligand RAE-1δ on tumor-infiltrating macrophages
Thompson, T. W., Jackson, B. T., Li, P. J., Wang, J., Kim, A. B., Huang, K. T. H., Zhang, L., & Raulet, D. H. (2018) · eLife · doi:10.7554/elife.32919 · Cited by 21
Self-citationUddin, M. B., Roy, K. R., Hill, R. A., Roy, S. C., Gu, X., Li, L., Zhang, Q.-J., You, Z., & Liu, Y. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113210 · Cited by 19
The therapeutic potential of natural killer cells in neuropathic pain
Kim, H. W., Wang, S., Davies, A. J., & Oh, S. B. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.05.008 · Cited by 19
NKG2D‐ligands: Putting everything under the same umbrella can be misleading
Campos‐Silva, C., Kramer, M. K., & Valés‐Gómez, M. (2018) · HLA · doi:10.1111/tan.13246 · Cited by 18
Li, Z., Yao, J., Xie, Y., Geng, X., & Liu, Z. (2016) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2016.01.002 · Cited by 16
Zhang, H., Li, N., Zhang, J., Jin, F., Shan, M., Qin, J., & Wang, Y. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1177678 · Cited by 14
Inflammatory Cytokine–Mediated Evasion of Virus-Induced Tumors from NK Cell Control
Mishra, R., Polić, B., Welsh, R. M., & Szomolanyi‐Tsuda, E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203328 · Cited by 14
Hu, J., Xia, X., Zhao, Q., & Li, S. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.12.002 · Cited by 11
Tanaka, M., Fine, J. H., Kirkham, C. L., Aguilar, O. A., Belcheva, A., Martín, A., Ketela, T. W., Moffat, J., Allan, D., & Carlyle, J. R. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1688 · Cited by 10
Targeting NKG2D/NKG2DL axis in cancer immunotherapy: mechanisms and therapeutic applications
Wei, H., Xiang, L., Zhou, Y., Huang, Y., Liu, L., & Cao, D. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-025-07650-5 · Cited by 9
IL-18-dependent NKG2D ligand upregulation on accessory cells is mediated by the PI3K/GSK-3 pathway
Brandstadter, J. D., Chen, H., Jiang, S., Huang, X., & Yang, Y. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.2a0816-342r · Cited by 8
Lis, N., Hein, Z., Ghanwat, S., Ramnarayan, V. R., Chambers, B. J., & Springer, S. (2021) · Journal of Cell Science · doi:10.1242/jcs.257428 · Cited by 7
“Markers and function of human NK cells in normal and pathological conditions.”
Lundqvist, A., & Kremer, V. (2017) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21520 · Cited by 6
Zhang, K., Liu, X., Han, M., Liu, Y., Wang, X., Yu, H., Liu, J., & Zhang, Q. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.06.035 · Cited by 5
Marrocco, R., Lucero-Meza, E., & Benedict, C. A. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf051 · Cited by 1
Activation and Function of Innate Lymphoid Cells
Land, W. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-78655-1_27 · Cited by 1
CellsSurveillance of Unhealthy Cells by Natural Killer
Iannello, A., & Raulet, D. H. (2013)
Self-citationUnderstanding the Mechanism of Stimulatory NK-cell Ligand Expression
Tokuyama, M. (2012) · eScholarship (California Digital Library)
Self-citationWelsh, R. M., & Waggoner, S. N. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.14007-x
Identification of cellular gene targets of anti-viral miR-27
Praihirunkit, P. (2015) · ERA
The Effect of Inflammatory Stimuli on Cryptic Peptide Presentation for Immune Surveillance
Prasad, S. (2014) · eScholarship (California Digital Library)
Role and Regulation of NKG2D Ligands on Tumors and Associated Cells
Thompson, T. W. (2017) · eScholarship (California Digital Library)
Baingo, J. (2018) · DuEPublico (University of Duisburg-Essen)
Mechanisms of Natural Killer Cell Activation to Viral Infection
Brandstadter, J. D. (2015) · DukeSpace (Duke University)
Baugh, R. T. (2022) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/bodleian:gpyyoakop
High systemic cholesterol and IFN-γ response in breast cancer cells
Botinas, D. A. S. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Baingo, J. (2018) · DuEPublico (University of Duisburg-Essen)
RAE-1, acteur et marqueur de la prolifération de cellules neurales
Popa, N. (2012) · theses.fr (ABES) · doi:10.70675/06fb8407z141ez4c9az9efdzde802eb989e6
Etude des mécanismes d'expression des ligands de NKG2D lors des syndromes lymphoprolifératifs
Ilias, W. (2017) · theses.fr (ABES) · doi:10.70675/e80e800ezf973z460dz8a42z437fdd7579df
Vaseq, R., Mahleqa, N., Mohammadi, A., Hübner, M. P., Weiher, H., & Schmidt‐Wolf, I. G. H. (2026) · Seminars in Immunopathology · doi:10.1007/s00281-026-01092-x
Metadata
- Authors
- Tokuyama, M., Lorin, C., Delebecque, F., Jung, H., Raulet, D. H., & Coscoy, L.
- Affiliations
- University of California, Berkeley (US)
- Corresponding author
- Coscoy, Laurent
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-09-22
- Volume
- 7
- Issue
- 9
- Pages
- e1002265
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3178570
- OpenAlex
- W2114917283
- Cited by
- 51
- References
- 59
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 4 · 2017: 3 · 2016: 5 · 2015: 4 · 2014: 6 · 2013: 10 · 2012: 4
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA093678)
- National Institute of Allergy and Infectious Diseases (R01AI039642, P01AI065831)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Keywords
- Rae1, NKG2D ligands, natural killer cells, PI3K signaling, p110α, murine cytomegalovirus, viral infection, cell transformation, NK cell activation, tumor surveillance
- MeSH terms
- Animals, Cell Transformation, Viral, Cytomegalovirus Infections, Fibroblasts, Killer Cells, Natural, Ligands, Muromegalovirus, Phosphatidylinositol 3-Kinases, Catalytic Domain, Nucleocytoplasmic Transport Proteins, Nuclear Matrix-Associated Proteins, Cell Line, Tumor, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K, Class I Phosphatidylinositol 3-Kinases, Phosphatidylinositol 3-Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.